Andrei R. Shustov, MDDr. Shustov specializes in treating T-cell non-Hodgkin's lymphoma, cutaneous T-cell lymphoma, Hodgkin's lymphoma, and acute lymphocytic leukemia
Patient Care Philosophy:
To provide state of the art patient care based on current advancements in clinical research and participation in well-designed clinical trials. “I believe every patient is different, and I try to find a unique individual approach to the patient and his disease within the boundaries of current standards of care and recent discoveries of clinical science.”
Dr. Shustov's Resume
- Assistant Professor, Hematology Division, University of Washington School of Medicine
- Assistant Member, Fred Hutchinson Cancer Research Center
Non-Hodgkin's and Hodgkin's lymphomas, T-cell lymphomas, acute lymphocytic leukemia, and Castleman’s disease
Education And Training
- MD: Crimea Medical Institute in Ukraine, 1993
- Residency Internal Medicine: York Hospital, York, PA, 2003
- Fellowship, Hematology/Medical Oncology Program: University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA, 2006
More InformationFor more information about Dr. Andrei R. Shustov's clinical and research expertise, click here.
- Vorinostat in Patients With Primary Cutaneous T-Cell Lymphoma (FH 6914)
- Inotuzumab Ozogamicin for Acute Lymphocytic Leukemia
- Brentuximab Vedotin for Non-Hodgkin Lymphoma (UW11026)
- Pralatrexate + Chemotherapy for Non-Hodgkin's Lymphoma (FH 7860)
- Two Doses of Fostamatinib for Large B-Cell Lymphoma (UW12019)
- Marqibo® for Older Patients w/ Newly Diagnosed ALL (20112071)
- KW-0761 (Mogamulizumab ) vs. Vorinostat for Relapsed/Refractory CTCL (20121464)
Dr. Shustov's Story
Andrei Shustov, MD, is an assistant professor at the University of Washington School of Medicine and an Assistant Member of Fred Hutchinson Cancer Research Center. He cares for his patients at Seattle Cancer Care Alliance and specializes in hematologic malignancies, such as non-Hodgkin's and Hodgkin's lymphomas, acute and chronic leukemias. He is especially interested in systemic T-cell lymphomas, cutaneous T-cell lymphomas, and Castleman’s Disease.
As a physician, his goal is to provide state-of-the-art patient care based on current advancements in clinical research and participation in well-designed clinical trials. “I believe every patient is different, and I try to find a unique individual approach to the patient and his disease within the boundaries of current standards of care and recent discoveries of clinical science,” Dr. Shustov says.
Dr. Shustov received his medical degree from the Crimea Medical Institute in Ukraine in 1993. He then moved to Maryland at the urging of a friend and fellow physician to perform research on graft-versus-host disease. After six years, he realized he missed patient care and took the medical boards and went to York Hospital in York, Penn. in 2003 for an Internal Medicine residency where he became interested in oncology. “And I liked working with the uniqueness of oncology patients and their families,” he says.
Dr. Shustov graduated from a Hematology/Medical Oncology Fellowship Program at the University of Washington and Fred Hutchinson Cancer Research Center in 2006. He now works alongside his mentors, Dr. David Maloney and Dr. Oliver Press treating and looking for new therapies for high-grade lymphomas.
When he isn’t working, Dr. Shustov is a “fanatic traveler” who prefers civilization-free vacations in the depths of the South American jungles where he can practice his other passion, wildlife photography.